Skip to main content
Clinical Trials/NCT01894841
NCT01894841CompletedNot Applicable

Veterans Coping Long-Term With Suicide

VA Office of Research and Development1 site in 1 country107 target enrollmentStarted: February 24, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
107
Locations
1
Primary Endpoint
Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Behavior

Study Overview

Brief Summary

The proposed study seeks to test the efficacy of an intervention to reduce suicide behaviors in Veterans. The Veterans Coping Long Term with Active Suicide Program (CLASP-VA) is an innovative, telephone-based intervention that combines elements of individual therapy, case management, and significant other/family therapy and is designed to be integrated into a VA system.

Detailed Description

Suicide is a leading cause of death for military personnel, and for the first time in recorded history, rates of military suicides are exceeding civilian rates. Despite public and patient health costs associated with suicidal ideation and behavior, existing efforts haven't appreciably reduced rates of suicidal behavior in the military. Consequently, finding novel, efficacious, and acceptable methods to reduce suicide behaviors is imperative. The Veteran's Coping Long Term with Active Suicide Program (CLASP-VA) is a unique suicide reduction intervention that directly targets high-risk patients at the time of hospital discharge. It is one of the few empirically-developed and promising interventions (e.g., strong pilot data) for individuals hospitalized for suicide behavior.

The primary objective of this study is to test the efficacy of the CLASP intervention compared to a treatment as usual plus Safety Assessment and Follow-up Evaluation (SAFE) control condition. Efficacy will be determined by primary outcomes including: number of attempts, number of re-hospitalizations, severity, and chronicity of suicidal ideation. A secondary objective is identifying the types of patients who receive the most benefit from the CLASP-VA intervention.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •suicide attempt or suicidal ideation with any methods, plan, and/or intent to make a suicide attempt within 1 week of hospitalization
  • •age greater than 18
  • •have a telephone
  • •ability to speak, read, and understand spoken English sufficiently well to complete the procedures of the study

Exclusion Criteria

  • •long-term psychiatric disorder
  • •diagnosis of borderline personality disorder
  • •cognitive impairment which would interfere with adequate participation in the project (MMSE <20)

Arms & Interventions

CLASP Intervention

Experimental

A 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.

Intervention: Coping Long Term with Active Suicide (CLASP) (Behavioral)

CLASP Intervention

Experimental

A 6 month adjunctive intervention consisting of 3 individual meetings, one family session, and 11 brief phone contacts with patient and identified significant other.

Intervention: Safety Assessment and Follow Up Evaluation (Other)

Safety Assessment and follow up Evaluation

Other

Treatment as usual plus enhanced monitoring.

Intervention: Safety Assessment and Follow Up Evaluation (Other)

Outcomes

Primary Outcomes

Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Behavior

Time Frame: baseline, 3, 6, 9, & 12 month post-hospitalization

Items measuring attempt behavior (number of Actual Attempts, number of Aborted Attempts, number of Interrupted Attempts) From the Columbia Suicide Severity Rating Scale were summed to create a composite variable indexing attempt behavior. Higher scores indicate more attempt behavior. We log transformed this variable at all time points to meet assumptions of normality.

Secondary Outcomes

  • Brief Symptom Inventory(Baseline, 3, 6, 9, & 12 month follow up)
  • Changes in Beck Hopelessness Scale(Baseline, 3, 6, 9, & 12 month follow up)
  • World Health Organization Disability Assessment Schedule (WHODAS) II(Baseline, 3, 6, 9, & 12 month follow ups)
  • Treatment History Interview(3, 6, 9, & 12 month follow up)
  • Changes in Columbia Suicide Severity Rating Scale (C-SSRS) - Ideation Severity(baseline, 3, 6, 9, & 12 month post-hospitalization)

Investigators

Sponsor Class
Fed
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Veterans Coping Long-term With Active... | Clinical Trial